KOD
Income statement / Annual
Last year (2023), Kodiak Sciences Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2023, Kodiak Sciences Inc.'s net income was -$260.49 M.
See Kodiak Sciences Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
| Operating Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Cost of Revenue |
$25.95 M |
$11.00 M |
$8.71 M |
$4.21 M |
$911,000.00 |
$490,000.00 |
$549,000.00 |
$257,000.00 |
| Gross Profit |
-$25.95 M |
-$11.00 M |
-$8.71 M |
-$4.21 M |
-$911,000.00 |
-$490,000.00 |
-$549,000.00 |
-$257,000.00 |
| Gross Profit Ratio |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| Research and Development
Expenses |
$206.30 M
|
$267.59 M
|
$217.34 M
|
$107.39 M
|
$37.51 M
|
$18.79 M
|
$22.02 M
|
$14.05 M
|
| General & Administrative
Expenses |
$71.02 M
|
$73.79 M
|
$49.71 M
|
$28.62 M
|
$11.68 M
|
$7.58 M
|
$3.50 M
|
$3.10 M
|
| Selling & Marketing
Expenses |
$45.00 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$71.02 M
|
$73.79 M
|
$49.71 M
|
$28.62 M
|
$11.68 M
|
$7.58 M
|
$3.50 M
|
$3.10 M
|
| Other Expenses |
$0.00 |
$503,000.00 |
-$215,000.00 |
$34,000.00 |
$265,000.00 |
-$4.07 M |
-$1.23 M |
$25,000.00 |
| Operating Expenses |
$277.32 M |
$341.38 M |
$267.05 M |
$136.01 M |
$49.19 M |
$26.37 M |
$25.52 M |
$17.15 M |
| Cost And Expenses |
$277.32 M |
$341.38 M |
$267.05 M |
$136.01 M |
$49.19 M |
$26.37 M |
$25.52 M |
$17.15 M |
| Interest Income |
$16.73 M |
$7.07 M |
$298,000.00 |
$2.90 M |
$1.57 M |
$0.00 |
$0.00 |
$0.00 |
| Interest Expense |
$13,000.00 |
$18,000.00 |
$22,000.00 |
$25,000.00 |
$8,000.00 |
$5.52 M |
$1.19 M |
$6,000.00 |
| Depreciation &
Amortization |
$18.30 M
|
$11.00 M
|
$8.71 M
|
$4.21 M
|
$911,000.00
|
$490,000.00
|
$549,000.00
|
$257,000.00
|
| EBITDA |
-$259.02 M
|
-$333.81 M
|
-$266.97 M
|
-$133.07 M
|
-$47.36 M
|
-$30.45 M
|
-$26.20 M
|
-$16.87 M
|
| EBITDA Ratio |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| Operating Income Ratio
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Total Other
Income/Expenses Net |
$16.83 M
|
$7.56 M
|
$61,000.00
|
$2.91 M
|
$1.83 M
|
-$9.55 M
|
-$1.23 M
|
$25,000.00
|
| Income Before Tax |
-$260.49 M |
-$333.82 M |
-$266.99 M |
-$133.10 M |
-$47.37 M |
-$41.44 M |
-$27.94 M |
-$17.13 M |
| Income Before Tax Ratio
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00 |
$7.35 M |
-$153,558.00 |
$2.73 M |
-$638,000.00 |
-$9.55 M |
-$45,000.00 |
$31,000.00 |
| Net Income |
-$260.49 M |
-$333.82 M |
-$266.99 M |
-$133.10 M |
-$46.73 M |
-$41.44 M |
-$27.94 M |
-$17.13 M |
| Net Income Ratio |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| EPS |
-4.97 |
-6.39 |
-5.16 |
-2.91 |
-1.23 |
-2.77 |
-1.05 |
-0.65 |
| EPS Diluted |
-4.97 |
-6.39 |
-5.16 |
-2.91 |
-1.23 |
-2.77 |
-1.05 |
-0.65 |
| Weighted Average Shares
Out |
$52.41 M
|
$52.25 M
|
$51.79 M
|
$45.74 M
|
$37.85 M
|
$14.98 M
|
$26.56 M
|
$26.56 M
|
| Weighted Average Shares
Out Diluted |
$52.41 M
|
$52.25 M
|
$51.79 M
|
$45.74 M
|
$37.85 M
|
$14.98 M
|
$26.56 M
|
$26.56 M
|
| Link |
|
|
|
|
|
|
|
|
